(June 15) Last month, the REDUSE trial passed a significant milestone by reaching 50% of its target for patient inclusion. This major threshold is an exciting development, as it reflects the interest
(May 25) Tammerfors University Hospital (Tays) in Tampere, Finland, became the second international site to commence patient recruitment for the REDUSE study. This exciting development comes just seve
(March 31) Linn Hemberg, an environmental science researcher in perioperative and intensive care, defended her thesis, "Critical Care, Critical Emissions: Applying life cycle assessment on intensive a
Comments